Hsbc Holdings PLC Reduces Stock Holdings in Cognex Corporation $CGNX

Key Points

• Hsbc Holdings PLC cut its Cognex stake by 28.2% in the second quarter, selling 16,375 shares and retaining 41,622 shares valued at approximately $2.98 million. Institutional investors and hedge funds collectively own 88.12% of Cognex.
• Cognex reported quarterly EPS of $0.45, exceeding estimates by $0.03, while revenue rose 16.9% year over year to $291.26 million. The company issued FY 2026 EPS guidance of $1.64–$1.68.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and a $75.64 price target versus the stock’s recent $61.69 price. Cognex also pays a quarterly dividend of $0.085 per share, yielding approximately 0.6%.

Hsbc Holdings PLC lowered its holdings in Cognex Corporation (NASDAQ:CGNX - Free Report) by 28.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 41,622 shares of the scientific and technical instruments company's stock after selling 16,375 shares during the quarter. Hsbc Holdings PLC's holdings in Cognex were worth $2,982,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Intech Investment Management LLC grew its holdings in Cognex by 124.5% during the fourth quarter. Intech Investment Management LLC now owns 98,451 shares of the scientific and technical instruments company's stock worth $3,542,000 after acquiring an additional 54,600 shares during the period. One Capital Management LLC acquired a new position in Cognex in the fourth quarter valued at approximately $1,945,000. Handelsbanken Fonder AB boosted its position in Cognex by 76.3% in the 4th quarter. Handelsbanken Fonder AB now owns 758,831 shares of the scientific and technical instruments company's stock worth $27,303,000 after purchasing an additional 328,427 shares in the last quarter. Legal & General Group Plc boosted its position in Cognex by 11.1% in the 4th quarter. Legal & General Group Plc now owns 1,152,053 shares of the scientific and technical instruments company's stock worth $41,451,000 after purchasing an additional 114,652 shares in the last quarter. Finally, New Age Alpha Advisors LLC acquired a new stake in shares of Cognex during the 4th quarter worth approximately $743,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Cognex Stock Performance

Cognex stock opened at $61.69 on Friday. The company's fifty day moving average price is $63.31 and its 200 day moving average price is $60.01. Cognex Corporation has a 1 year low of $34.60 and a 1 year high of $72.88. The stock has a market capitalization of $10.38 billion, a P/E ratio of 59.89 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.42 by $0.03. The company had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm's revenue was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Sell-side analysts predict that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were given a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Thursday, August 20th. Cognex's dividend payout ratio is 33.01%.

Analyst Upgrades and Downgrades

CGNX has been the subject of several recent research reports. Weiss Ratings raised shares of Cognex from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Barclays restated an "overweight" rating and set a $80.00 price target (up from $75.00) on shares of Cognex in a research report on Monday, August 10th. Seaport Research Partners set a $75.00 price objective on shares of Cognex in a research report on Tuesday, May 26th. Needham & Company LLC increased their target price on shares of Cognex from $75.00 to $80.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, Zacks Research upgraded Cognex from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 16th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.64.

Cognex Company Profile

Cognex Corporation NASDAQ: CGNX develops machine vision technologies that help businesses automate inspection, identification, measurement and guidance tasks. Its systems enable manufacturing and logistics operations to analyze images and make decisions about products, components and packages.

The company's product portfolio includes industrial cameras, vision sensors, barcode readers, three-dimensional vision systems and machine vision software. Cognex also offers artificial intelligence and deep-learning tools designed to address complex inspection and classification applications, along with engineering, implementation and support services.

Founded in 1981 by Robert J.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.